Catalent has announced a multi-year $350 million investment at its plant in Bloomington, Indiana after months of speculation. In February, various publications, including B Square Bulletin, reported that contract development manufacturing organization (CDMO) Catalent is looking to spend $350 million at its Bloomington, Indiana facility with the City of Bloomington supposedly offering the firm millions of dollars in tax breaks. The city council is said to have unanimously voted in favour of the tax breaks two months ago, but a further vote…

Thermo Fisher says its manufacturing site in Ogden, Utah increases production of single-use bioprocess containers, which are crucial to developing vaccines and therapies. According to Thermo Fisher Scientific, the opening of its 55,000 square-foot single-use technology (SUT) facility in Ogden is part of a long-term $650 million investment the firm announced last March. Thermo claims that the plant provides additional capacity to produce various technology and materials needed for the development of emerging vaccines and breakthrough therapies. The facility will manufacture…